Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Leading Clinical Toxicology Organizations Issue Joint Statement on Dangers of Oleandrin Toxicity


American College of Medical Toxicology

American College of Medical Toxicology

“In the strongest terms possible, we recommend against the use of oleandrin outside of rigorous, medically-supervised clinical research with regulatory oversight, and we implore consumers to not rush to use an untested remedy with potentially life-threatening toxicity.”

The American College of Medical Toxicology (ACMT), the American Academy of Clinical Toxicology (AACT), and the American Association of Poison Control Centers has issued the following joint statement in response to recent discussions proposing the use of oleandrin as a potential treatment for COVID-19:

As physicians, pharmacists, and experts in pharmacology and poisoning, we are extremely concerned, based on the available scientific data and our clinical experience, about the proposed use of oleandrin for treatment of COVID-19.

Oleandrin is a cardioactive steroid extracted from the oleander plant (Nerium oleander). Each year, exposures to oleander and related compounds result in thousands of poisonings worldwide. These drugs are cardiac poisons capable of causing bradycardia (slow heart rate), dysrhythmias (irregular heartbeats), and death.

Although closely-related compounds such as digoxin are used to treat heart failure and atrial fibrillation, these medications are rigorously tested, FDA-approved, pharmaceutically produced, and their place in therapy has been established over decades of use. Even when used appropriately, blood levels must be closely monitored to prevent toxicity. Treatment of toxicity from cardioactive steroids is expensive and, unfortunately, not always successful.

We are aware of a preprint publication suggesting that oleandrin may inhibit the replication of SARS-CoV-2 in vitro. This is true of many other chemicals, as well. This does not mean oleandrin is safe or effective for the treatment or prevention of coronavirus in humans. It is often the case that drugs that appear effective in “test tube” or animal models are found to be ineffective or harmful in humans. Before any treatment can be seriously considered for any disease, it needs to be rigorously studied for both safety and efficacy. If oleandrin is to be seriously considered as a potential coronavirus treatment, we expect to see peer-reviewed research for that use.

As physicians, scientists, and citizens, we share the desire for effective treatments for this devastating pandemic. However, a potentially dangerous treatment with no evidence of benefit is worse than no treatment at all. Preparations made from oleander are available for purchase, but we caution consumers strongly against the use of capsules, tablets, or teas, or any product made from this plant. People with suspected oleandrin toxicity should be managed in consultation with a clinical toxicologist. Patients and clinicians can reach their regional poison center at 1-800-222-1222, 24 hours/7 days a week/365 days a year.

In the strongest terms possible, we recommend against the use of oleandrin outside of rigorous, medically-supervised clinical research with regulatory oversight, and we implore consumers to not rush to use an untested remedy with potentially life-threatening toxicity.

Sincerely,

American College of Medical Toxicology, Board of Directors

American Academy of Clinical Toxicology, Board of Trustees

American Association of Poison Control Centers

View/download original statement here.

Experts in Medical Toxicology from ACMT are available for further comment and consultation on this subject. Please contact communications@acmt.net.

About ACMT

The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology. Our members specialize in the prevention, evaluation, treatment, and monitoring of injury and illness from exposures to drugs and chemicals, as well as biological and radiological agents. We care for people in clinical, academic, governmental, and public health settings, and provide poison control center leadership.

Share article on social media or email:

Simply Dental Management Earns Spot on the Inc. 5000 for the Second Consecutive Year, Growing 165.87%


We are thrilled to make the Inc. 5000 again this year. This achievement is a testament to our teams’ dedication and passion for creating smiles.

Simply Dental Management, a leading dental support organization in the Northeast, today announced it ranked No. 2494 on the annual Inc. 5000 list, the most prestigious ranking of the nations’ fastest-growing private companies. The Inc. magazine list represents a unique look at the most successful companies within the American economy’s most dynamic segment – its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“We are thrilled to make the Inc. 5000 again this year,” said Dr. Sam Alkhoury, DMD, president and clinical director of Simply Dental Management. “Our team works tirelessly to ensure our patients enjoy the same familiar, personalized and safe experience at all of our clinics while we grow at a rapid pace. This achievement is a testament to their dedication and passion for creating smiles.”

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists as well. The 2020 Inc. 5000 achieved an incredible three-year average growth of more than 500%, and a median rate of 165%. The Inc. 5000’s aggregate revenue was $209 billion in 2019, accounting for more than 1 million jobs during the past three years.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

About Simply Dental Management

Simply Dental Management is New England’s leading dental and orthodontic support organization with more than 35 practices across the region. The company enables practices to enjoy the benefits of a centralized support team across critical business functions, including HR, IT, operations, marketing, procurement, billing and collections, call center and compliance so that clinical teams can focus on patient needs. Practices offer various services ranging from orthodontia to general and pediatric dentistry, oral surgery and periodontics. Founded in 2016 by Dr. Sam Alkhoury, Simply Dental Management simplifies the business of oral care. For more information, visit http://www.simplydentalmanagement.com or follow us on Facebook and LinkedIn.

Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

Share article on social media or email:

New Global Heart Failure Academy Website Aims to Improve the Fundamentals of Heart Failure Patient Care


News Image

Heart failure is a journey. We owe it to our patients to be the best possible guide for their well-being.

Medtelligence, a leading provider of cardiovascular disease education, announces the launch of the Global Heart Failure Academy, a comprehensive online curriculum designed to improve clinical behavior in the recognition and diagnoses of hyperkalemia (HK) and iron deficiency (ID) in heart failure. While clinical guidelines address both HK and ID, there remain gaps in practice that show large differences in the rate of treatment for both HK and ID, putting patients at much greater risk.

“Heart failure is a journey,” said Javed Butler, MD, MPh, MBA, and Co-chair of the Global Heart Failure Academy. “We owe it to our patients to be the best possible guide for their well-being.”

Butler is joined by seven additional renowned physicians who serve on the Steering Committee and provide insights through the application of emerging science into everyday practice. Members include Co-chair Giuseppe Rosano, MD, PhD; Michael Böhm, MD; Josep Comin-Colet, MD, PhD; Gregg C. Fonarow, MD; Ileana L. Piña, MD, MPH, FAHA, FACC; Mikhail Kosiborod, MD; and Austin Stack, MD, MBBCh, MSc.

“Registry data have shown that heart failure management varies substantially and is often implemented without the full use of the clinical tools that providers have available to them,” said Co-chair Guiseppe Rosano, MD, PhD. “We are demonstrating how registry data is key to improving patient management.”

Medtelligence President Kathleen Wickman, BSN, said, “In a recent survey we conducted through the ReachMD Network, we found that about half of physician respondents had never used a potassium binder to treat HK. This is one of the many reasons we launched a global curriculum—to change the care and outcomes of patients with heart failure.”

The target audiences for the GHFA curriculum include cardiologists, nephrologists, endocrinologists, and primary care physicians. Educational interventions include:

1.    Expert Interviews

2.    Panel Discussions

3.    Podcast Plus (animated podcasts)

4.    3D Modeling of Mechanism of Action

5.    DecisionSim Branched Learning

The Global Heart Failure Academy is developed by Medtelligence and supported by an unrestricted educational grant by Vifor Pharma.

About Medtelligence

Medtelligence is a global leader in cardiovascular, diabetes, and CKD medical education, offering digital education and live meetings across the globe. Medtelligence is a member of the Global Learning Collaborative (GLC), which also includes Omnia Education, Prova Education, and the Academy for Global Interprofessional Learning & Education (AGILE). GLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Share article on social media or email:

NCPDP Announces Call for Proposals for its 2021 Annual Technology & Business Conference, “Reimagine, Reinvent, Reinvest”


NCPDP

NCPDP announced today the Call for Proposals for its 2021 Annual Technology & Business Conference, “Reimagine, Reinvent, Reinvest,” which will be held May 3-5, 2021, at the Westin Kierland Resort & Spa in Scottsdale, Arizona. NCPDP’s national conference draws more than 700 attendees from across the healthcare industry, including technical, business and executive representatives from health plans, pharmacy benefit managers, retail and independent pharmacies, specialty pharmacies, long-term care providers, healthcare consultants, technology vendors, pharmaceutical manufacturers, wholesale drug distributors, database management organizations and others.

“Our 2021 Annual Conference theme, ‘Reimagine, Reinvent, Reinvest,’ are calls to action for healthcare industry stakeholders to step into a new mindset where anything is possible – to envision what healthcare and the patient experience should be and could be’” explained Lee Ann Stember, NCPDP’s President & CEO. “The next step is to take our shared, altruistic aspirations and be creative by reinventing. For example, the great, foundational standards we have can be repurposed to facilitate data sharing in a new way or for a new purpose. Then we must ground ourselves in the work to make it happen by reinvesting our time in developing and enhancing standards and solutions for the common good. This means bringing more colleagues and competitors together in our forums to continue our important work.”

NCPDP is accepting submissions for two different session formats:

  • Standard Track Sessions are 60-minute sessions, providing for a 45-minute presentation and 15 minutes of question and answer. These sessions are limited to a maximum of two (2) speakers.
  • Rapid-fire, Hot Topic Sessions are 30-minute sessions focused on a high-level overview of an emerging trend. These sessions are designed to be both cutting-edge and highly focused, requiring the presenter to share ideas and achieve learning objectives in 20 minutes, with the remaining 10 minutes open for interactive discussion.

NCPDP encourages the submission of proposals covering a broad range of educational, informative healthcare and pharmacy topic areas, such as:

  • Artificial Intelligence
  • Behavioral Nudges
  • Blockchain Technology
  • Compliance, Accreditation, Government Mandates and Audits, HIPAA
  • Data and Analytics
  • Digital Therapeutics, Technology
  • Emerging Pharmacy Treatments
  • Emerging Technologies
  • Food and Drug Administration Programs
  • Impact of Regulatory/Legislative Environment on NCPDP Standards, Membership, Priorities
  • Long-term Care, Hospice
  • Pharmacogenomics
  • Population Health Management
  • Precision Medicine
  • Medicaid and Medicare Programs
  • Medication Adherence, Medication Management
  • mHealth (mobile health)
  • Patient Experience, Patient Engagement
  • Pharmacist as Provider, Pharmacist Provided Patient Care
  • Pharmacy Quality Measures
  • Rebates, Chargebacks
  • Social Determinants of Health
  • Specialty Pharmacy
  • Standards & Interoperability
  • Telehealth
  • Value Based Care
  • Wearables Data
  • 340B Drug Discount Program

Preference will be given to case studies, pilot results and emerging trends. The deadline to submit a proposal is October 5, 2020.

For more information or to submit a proposal, visit: https://ncpdp.org/ac/call-for-proposals-info.aspx. For real-time updates before and during the conference, follow us at http://twitter.com/ncpdp or join the discussion using NCPDP’s 2021 Annual Technology & Business Conference hashtag: #NCPDP21.

About NCPDP

Founded in 1977, NCPDP is a not-for-profit, ANSI-accredited, Standards Development Organization with more than 1,700 members representing virtually every sector of the pharmacy services industry. Our diverse membership provides leadership and healthcare business solutions through education and standards, created using the consensus building process. NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for ePrescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data products include dataQ®, a robust database of information on more than 80,000 pharmacies, resQ™, an industry pharmacy credentialing resource, and HCIdea®, an innovative prescriber database that provides continually updated information on more than 2.5 million prescribers. NCPDP’s RxReconn® is a legislative tracking product for real-time monitoring of pharmacy-related state and national legislative and regulatory activity. For more information about NCPDP Standards, Data Services, Products, Educational Programs and Work Group meetings, go online at http://www.ncpdp.org or call 480.477.1000.

Share article on social media or email:



Dr. Rod J. Rohrich Implements Enhanced Patient Safety Protocols for Plastic Surgery in Response to Coronavirus Pandemic


Dallas Plastic Surgeon Dr. Rod J. Rohrich

Dallas Plastic Surgeon Dr. Rod J. Rohrich

Patient safety has always been and remains a top priority in my practice at the Dallas Plastic Surgery Institute (DPSI).

Dallas plastic surgeon, Dr. Rod J. Rohrich has implemented a series of enhanced patient safety protocols for his clinic and staff in response to the ongoing COVID-19 pandemic.

“Patient safety has always been and remains a top priority in my practice at the Dallas Plastic Surgery Institute (DPSI),” explains Dr. Rohrich. “Early on in the pandemic, we established protocols for DPSI, Dallas Day Surgery Center (DDSC), the EpiCentre and the Cloister Hotel. Most of these practices were already in place but we added further precautions to protect the health and well-being of our patients, our dedicated staff, and the community at large.”

As Texas plastic surgeons begin opening their operating rooms and consultations for elective surgery to resume following the extended lockdown, Dr. Rohrich is assuring his patients that the utmost care has been taken to keep them safe and reduce their risks during the COVID-19 outbreak. Dr. Rohrich and his team continually review and evolve their policies as new COVID-19 information in released.

“We follow CDC and local government guidelines at all times and reopened our operating rooms following their policies as well as those of the American Society of Plastic Surgeons. Our facilities have been fitted with HEPA filters and all staff has received special Covid-19 training. We are performing all plastic surgery procedures with confidence in patient safety at Dallas Day Surgery Center. Online consultations and follow-up visits are now a high priority through our HIPAA compliant consultation service.”

Among the safety protocols implemented by Dr. Rohrich are no-touch temperature readings for all patients and staff entering the facility and a mandatory mask policy at all times (which can be relaxed only while being seen in an exam room for facelift and rhinoplasty patients, for example). Only essential personnel are present for procedures and patients are restricted to one family member or friend to accompany them to their procedures or clinic visits. All employees and staff must “Foam in and Foam out” prior to entering and leaving each exam room, hotel room, or operating room. Those entering the operating room must change scrubs if going in and out of DDSC and must remove hats, masks, and shoe covers when leaving DDSC.

Dr. Rohrich has also set a new policy of no shaking hands or even using fist bumps. Non-touch greetings (i.e. bowing, namaste, hand over heart) are ideal and superior to elbow bumps. If employees, patients or their family members are demonstrating any type of symptoms, they are not permitted to enter DPSI facilities until they have been assessed by their physician.

Furthermore, employee travel has been limited, particularly internationally. Employees take a COVID-19 test when returning from an absence requiring a plane flight. All must be responsible and practice social distancing. This means limiting unnecessary external events, limiting exposure to groups over ten, and standing at least six feet from others.

“We only needed to add a few new strategies to our patient safety protocols already in place,” said Dr. Rohrich. “While this pandemic may have taken away some of the personal touches we provided in our practice, patient safety and quality of care are still at the highest standard.”

About Dr. Rohrich

Dr. Rod J. Rohrich is a board certified plastic surgeon in Dallas, Texas. He is considered one of the most influential surgeons in this century. He is a Clinical Professor of Plastic Surgery at Baylor College of Medicine and was the first Chair of the Department of Plastic Surgery as well as the first plastic surgeon selected as a Distinguished Teaching Professor at UT Southwestern Medical Center. He graduated from Baylor College of Medicine with high honors, and completed his plastic surgery training at the University of Michigan Medical Center and fellowships at Massachusetts General Hospital/Harvard (hand/microsurgery) and Oxford University (pediatric plastic surgery). He is Chair of the Dallas Rhinoplasty Meeting, Founding Chair of the Dallas Cosmetic Surgery and Medicine Meeting, Founding Member of the Alliance in Reconstructive Surgery, and a Founding Partner of the Dallas Plastic Surgery Institute.

Dr. Rohrich also serves as the Editor-in-Chief of the most respected global peer reviewed plastic surgery journal – the Journal of Plastic and Reconstructive Surgery. He developed and is Editor-in-Chief of the first open access peer reviewed plastic surgery journal, PRS Global Open. Dr. Rohrich has published over 900 peer reviewed articles and six textbooks in plastic surgery

Dr. Rohrich also served as president of the American Society of Plastic Surgeons (ASPS), the largest organization of board certified plastic surgeons in the world. He repeatedly has been selected by his peers as one of America’s best doctors. He received the ASPS Special Achievement Award and on three occasions has received one of his profession’s highest honors, the Plastic Surgery Educational Foundation Distinguished Service Award, which recognizes his contributions to education in plastic surgery.

Share article on social media or email:

Dr. Christine Blaine of Blaine Plastic Surgery Now Offering the Ultra-Modern “Miracle Facial Lift,” Known as the Y LIFT


News Image

The Y LIFT is an ideal solution for restoring a youthful appearance in a way that looks completely natural. It is safe, effective and produces instant results with no downtime, says Dr. Christine Blaine

Dr. Christine Blaine and her all-female staff always welcome the opportunity to provide advanced techniques and procedures to assist patients in looking their best. Throughout the aging process, the face loses youthful volume, bone density, and skin elasticity, resulting in wrinkles and sagging skin. The Y LIFT is an innovative, minimally invasive procedure that enhances facial contours and replenishes lost volume and definition, reflecting an enhanced, rejuvenated and natural appearance. The Y LIFT resurrects and accentuates the cheekbone region, revives under-eye hollowness, defines the jawline, rids unpleasant jowls and revitalizes the upper neck area, all while producing instant results. The Y LIFT utilizes a special titanium instrument that is inserted beneath the skin and uses dermal fillers, containing naturally occurring hyaluronic acid, quickly lifting and contouring the muscles, fascia and fat. The rejuvenated face is then sculpted to accent, enhance and highlight the individual’s natural beauty. The Y LIFT is performed under a local anesthetic; patients may immediately resume daily activities post-procedure.

“The Y LIFT is an ideal solution for restoring a youthful appearance in a way that looks completely natural. It is safe, effective and produces instant results with no downtime,” says Dr. Christine Blaine

More about Blaine Plastic Surgery:

Christine Blaine, M.D., FACS is a board-certified plastic surgeon with three New York offices in Huntington, Staten Island and the newly opened location at The Parlor NYC. Dr. Christine Blaine has earned a stellar reputation as one of the best New York plastic and cosmetic surgeons. Blaine Plastic Surgery offers a wide menu of personalized services, including surgical and non-surgical facial rejuvenation, body sculpting, breast surgery and intimate plastic surgery. Dr. Blaine provides a compassionate approach, using the latest advanced technology to create natural and lasting results for her patients.

To schedule a Y LIFT consultation or to find out more about the office locations and procedures offered at Blaine Plastic Surgery, please call (631)-336-2984, or visit the website at http://www.blaineplasticsurgery.com.

Share article on social media or email:

NeoTract Designates Dr. Ryan Nelson as UroLift® Center of Excellence


News Image

“We are pleased to recognize Dr. Ryan Nelson as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Ryan Nelson, D.O., Michigan Institute of Urology in Utica, MI, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Nelson has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are pleased to recognize Dr. Ryan Nelson as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “This achievement has helped many patients experience durable, long- term relief from the burdensome symptoms of BPH while preserving sexual function*1,2.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

U.S. Dermatology Partners is pleased to welcome Fellowship-Trained Mohs Surgeon, Leon Chen, MD to their Houston Medical District location


Houston Mohs Surgeon, Leon Chen, MD

Leon Chen, MD

“Dr. Chen is super bright, super-nice, very talented surgically, and a great addition to U.S. Dermatology Partners!” Said, Dr. Mark Price

U.S. Dermatology Partners is excited to welcome Board-Certified Dermatologist and Fellowship-Trained Mohs Surgeon Leon Chen, MD to its Houston Medical District office.

Leon Chen earned his Medical Doctorate from the University of Texas McGovern Medical School and completed his dermatology residency training at MD Anderson Cancer Center/University of Texas McGovern Medical School combined program and his Micrographic Surgery and Dermatologic Oncology (Mohs) fellowship at MD Anderson Cancer Center. He was the winner of the Review Article Incentive Program awarded by the American Society for Dermatologic Surgery (ASDS) during his time as a dermatology resident. His fellowship training focused on Mohs micrographic surgery, advanced reconstruction, and clinical research in cutaneous oncology. He was the sub-investigator of various clinical trials that evaluated the use of a hedgehog pathway inhibitor and immunotherapy for advanced nonmelanoma skin cancer. Dr. Chen’s deep passion for skin cancer has led him to author more than 30 peer-reviewed research manuscripts and numerous book chapters. His research has been presented at national and international dermatology meetings. He is also the editor of the textbook, Basal Cell Carcinoma: Advances in Treatment and Research.

Chen joins highly regarded Fellowship-Trained Mohs Surgeon Mark Price, MD. Price has practiced in Houston since 1996 and has been recognized by peers in Texas Monthly in the prestigious Super Doctors Edition since the inception of the award.

“Dr. Chen is super bright, super-nice, very talented surgically, and a great addition to U.S. Dermatology Partners!” Said, Dr. Mark Price

In his free time, Dr. Chen enjoys spending time with his wife, Patty, and two young boys, Levi and Luke. He is also an avid sports fan who follows the Rockets, the Texans, the Astros as well as sports teams from his alma mater Texas Longhorns.

Dr. Chen is accepting referrals. For more information or to schedule a consultation, call 713-528-8882.

About U.S. Dermatology Partners

As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners’ patients not only have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network but also benefit from the practice’s strong dermatology subspecialty thought leaders and medical advisory board. To be the best partners to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.

Share article on social media or email:

The American Foundation of Savoy Orders (Savoy Foundation) Grants $360,000 During Covid Crisis


American Foundation of Savoy Orders, Incorporated

This crisis has placed increased burdens on college students, homeless families, inner-city families, elderly care institutions and churches whose financial resources funding community-based, essential services have been impacted because of closed facilities instigated by the pandemic.

The American Foundation of Savoy Orders (Savoy Foundation) today announced record setting grants of $360,000 to support children’s welfare causes, elder care, university scholarships, education programs and church support for essential community services during the unprecedented COVID-19 health and economic crisis.

Savoy Foundation Chairman of the Board Carl J. Morelli and President Joseph Sciame in a joint statement said: “This crisis has placed increased burdens on our college students, homeless families struggling to feed their children, on inner-city families struggling to find substitutes for summer camp programs for their children, on elderly care institutions and churches whose financial resources funding community-based, essential services have been impacted because of closed facilities instigated by the pandemic.”

New York Foundling’s Summer Camp Program – $130, 000 raised through the Foundation’s New York Ballo di Savoia in December 2019, for the New York Foundling’s Summer Camp Program- $50,000 for the 2020 Virtual Camp and $80,000 for the 2021 Live Summer Camp

Caterina’s Club – $100,000 to Caterina’s Club in Anaheim, California, raised through the Foundation’s 2020 Virtual Notte di Savoia Los Angeles to increase meal production and distribution for homeless/motel families in need and which will provide meals to homeless/motel children deprived of supplemental school meals during the pandemic

Savoy Foundation’s Education and Operating Endowment – $100,000 matching gift raised from a generous donor and granted to the Foundation’s Permanent Education and Operating Endowments

Savoy Orders Pigott Scholarships – $10,000 in grants from the Savoy Orders Pigott Scholarships Fund to support university students in International Studies and the Humanities

Mercy Ships – $10,000 grant to Mercy Ships for pediatric surgeries in impoverished countries

Providence Rest – $5,000 grant to Providence Rest Home for the relief and care of the elderly

Cathedral of Saint Patrick – $6,000 in grants to this iconic spiritual symbol of faith and hope

For more information on the philanthropic causes and programs supported by the Savoy Foundation, please : click here.

Businesses, individuals and organizations can donate here.

ABOUT THE AMERICAN FOUNDATION AND THE AMERICAN DELEGATION OF SAVOY ORDERS

Headquartered in New York City, the American Delegation of Savoy Orders, which includes all 50 of the United States of America, is among the 35 delegations of the Savoy Orders located throughout Europe, the Americas and Japan.

The American Foundation of Savoy Orders, Incorporated a tax-exempt 501 (c) (3) charitable organization, has supported local, national, and international charities focusing on medical, educational, and humanitarian fields, including philanthropy for U.S. veterans, hospitals and relief agencies for children, the poor, sick and elderly. The Foundation is a Non-Governmental Organization in Roster Consultative Statues with the Economic and Social Council of the United Nations. In 2019, the Savoy Foundation launched a new charitable initiative – Chivalry for Children’s Causes – a multi-year program assisting institutions and charitable organizations that provide aid to children and families in need, building stable, healthy families. The program is made possible thanks to generous support from the members and friends of the American Delegation of Savoy Orders.

Share article on social media or email:

Natural Stacks Now Has QR Codes On All Product Labels Giving Customers Full Access To It’s Supply Chain and Batch-By-Batch Lab Testing


Natural Stacks, a leading supplement company focused on brain health, has recently taken steps to improve their already successful “Open Source” transparency program by adding QR codes to all of their supplement bottles.

When a customer scans the QR code with their smartphone, they are taken directly to a webpage with information about the supplier for each ingredient in the formula, as well as access to the 3rd party lab test results for the most recent batch of that particular product.

The 3rd party test results, provided by Intertek allow the customers to verify:

  • Potency: The third party lab tests show the exact amount of each and every ingredient.
  • Purity: Standardized identity testing ensures the authenticity of the ingredients. This proves every ingredient is in its natural state and has not been adulterated.

These QR codes are located on the back of the bottle just below the “Suggested Use” section with the title “CERTIFIED OPEN SOURCE: Scan for Ingredient Supplier Information and 3rd Party test results.”

This addition of the QR code makes it even easier for customers to verify that they are ingesting a quality product that is what the label claims it to be. The bottle QR codes are an important piece in Natural Stacks’ commitment to being a fully “Open Source” Supplement Company.

Natural Stacks defines their “Open Source” program through three major pillars:

  • Ingredient Traceability: Natural Stacks controls which ingredient suppliers their manufacturers are allowed to use, and clearly display the ingredient supplier information on their website.
  • Third Party Lab Testing: Natural Stacks has partnered with Intertek, a respected ISO, ANS, and IEC accredited laboratory, to ensure the potency and purity of every ingredient after each production.
  • Full Label Disclosure: Natural Stacks always discloses the exact form of each ingredient and never uses proprietary formulas in their products so that customers understand what they are putting into their bodies.

This commitment to transparency is not typically seen in the supplement industry and sets Natural Stacks apart from their competition. The addition of QR codes to Natural Stacks supplement bottles allows customers to feel confident that they are using a quality product with quality ingredients.

About Natural Stacks

Natural Stacks is an innovative supplement company focused on producing supplements in the Brain Health category. By partnering with the world’s leading ingredient suppliers and manufacturers, they have been able to leverage patented technology and breakthrough research to create premium quality natural brain supplements. Their fast-growing, loyal customer base is a testament to their approach of providing full transparency and the highest quality ingredients possible.

Share article on social media or email: